![Rebecca Taub](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rebecca Taub
Fondatore presso
MADRIGAL PHARMACEUTICALS, INC.
Patrimonio netto: 551 M $ in data 31/05/2026
Profilo
Rebecca A. Taub was the founder of Madrigal Pharmaceuticals, Inc., founded in 2011, where the title held was Chief Executive Officer in 2011.
Dr. Taub is also the founder of Madrigal Pharmaceuticals, Inc., founded in 2000, holding the title of Director starting in 2025.
The current job is Independent Director at BriaCell Therapeutics Corp.
since 2019.
Former jobs include Executive Director-CNS & Obesity Research at Bristol Myers Squibb Co. from 2000 to 2003, Executive Director-CNS & Obesity Research at DuPont Pharmaceuticals Co. from 2000 to 2003, Vice President-Research at Roche Pharmaceuticals, Inc., Professor at the University of Pennsylvania from 1987 to 2002, Vice President-Research & Metabolic Diseases at Hoffmann-La Roche, Inc. from 2004 to 2007, Associate Investigator at Howard Hughes Medical Institute, Inc., Senior Vice President-Research & Development at VIA Pharmaceuticals, Inc. from 2008 to 2011, Assistant Professor at Harvard Medical School, and Professor at Perelman School of Medicine in 2001.
Education includes a doctorate from Yale School of Medicine and an undergraduate degree from Yale College.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 17/06/2026 | 1.108.207 ( 4,81% ) | 551 M $ | 31/05/2026 | |
| 28/01/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Posizioni attive di Rebecca Taub
| Società | Posizione | Inizio |
|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. | Fondatore | 10/03/2000 |
| BRIACELL THERAPEUTICS CORP. | Direttore/Membro del Consiglio | 07/03/2019 |
Precedenti posizioni note di Rebecca Taub
| Società | Posizione | Fine |
|---|---|---|
| VIA PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 01/01/2011 |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Direttore Tecnico/Scientifico/R&S | 01/01/2008 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/2003 |
DuPont Pharmaceuticals Co.
 DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Provides researches and develops pharmaceuticals and imaging products to treat diseases | Corporate Officer/Principal | 01/01/2003 |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2002 |
Formazione di Rebecca Taub
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
80
Relazioni di 1° grado
14
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 14 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Commercial Services |
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Provides researches and develops pharmaceuticals and imaging products to treat diseases | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Health Technology |
Howard Hughes Medical Institute, Inc.
 Howard Hughes Medical Institute, Inc. Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
VIA Pharmaceuticals, Inc.
 VIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops compounds for the treatment of cardiovascular and metabolic disease | Health Technology |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Madrigal Pharmaceuticals, Inc. /Old/
 Madrigal Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops small-molecule drugs addressing major unmet needs in cardiovascular and metabolic diseases | Health Technology |
Perelman School of Medicine
 Perelman School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale School of Medicine
 Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale College
 Yale College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BriaCell Therapeutics Corp.
 BriaCell Therapeutics Corp. BiotechnologyHealth Technology Operates as an immuno-oncology biotechnology company which develops targeted approaches for the management of breast cancer | Health Technology |
Madrigal Pharmaceuticals, Inc.
 Madrigal Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops small-molecule drugs for cardiovascular, metabolic and liver diseases | Health Technology |
